UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
(Mark One)
For
the quarterly period ended
For the transition period from __________ to ___________
Commission
file number:
(Exact name of registrant as specified in its charter)
| (State of Incorporation) | (IRS Employer ID Number) |
(Address of Principal Executive Offices)
(Registrant’s Telephone number)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| N/A | N/A | N/A |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.
| ☒ | No | ☐ |
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 for Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
| ☒ | No | ☐ |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| ☒ | Smaller reporting company | ||
| Emerging growth company | |||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
| Yes | ☐ | No |
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As of May 18, 2025, there were shares of the registrant’s common stock, $ par value, issued and outstanding.
TABLE OF CONTENTS
| i |
LIMITLESS X HOLDINGS INC.
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
LIMITLESS X HOLDINGS INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
| (Unaudited) | ||||||||
| March 31, | December 31, | |||||||
| 2025 | 2024 | |||||||
| ASSETS | ||||||||
| Current Assets: | ||||||||
| Cash | $ | $ | ||||||
| Accounts receivables, net | ||||||||
| Inventories | ||||||||
| Prepaid expenses | ||||||||
| Total current assets | ||||||||
| Non-Current Assets: | ||||||||
| Property and equipment, net | ||||||||
| Other assets | ||||||||
| Total non-current assets | ||||||||
| Total assets | $ | $ | ||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable and accrued expenses | $ | $ | ||||||
| Accrued interest | ||||||||
| Royalty payable | ||||||||
| Refunds and chargeback payable | ||||||||
| Note payable | ||||||||
| Notes payable to shareholder | ||||||||
| Notes payable to related parties | ||||||||
| Loan payable | ||||||||
| Total current liabilities | ||||||||
| Total liabilities | ||||||||
| Commitments and contingencies | ||||||||
| Preferred Stock B - $ par value; authorized shares; shares issued and outstanding, respectively | ||||||||
| Preferred Stock C - $ par value;
authorized shares; shares issued and outstanding | ||||||||
| Stockholders’ deficit | ||||||||
| Preferred Stock A - $
par value; authorized shares; shares issued and outstanding | ||||||||
| Preferred Stock D - $
par value; authorized shares; shares issued and outstanding | ||||||||
| Common Stock- $ par
value; authorized shares; shares and shares issued and outstanding, respectively | ||||||||
| Common stock issuable, shares | ||||||||
| Additional paid-in-capital | ||||||||
| Accumulated deficit | ( | ) | ( | ) | ||||
| Total stockholders’ deficit | ( | ) | ( | ) | ||||
| Total liabilities and stockholders’ deficit | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 1 |
LIMITLESS X HOLDINGS INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| Three Months Ended March 31, | ||||||||
| 2025 | 2024 | |||||||
| Net Revenue | ||||||||
| Product sales | $ | $ | ||||||
| Total net revenue | ||||||||
| Cost of Revenue | ||||||||
| Cost of revenue | ||||||||
| Total cost of sales | ||||||||
| Gross profit | ||||||||
| Operating expenses: | ||||||||
| General and administrative | ||||||||
| Advertising and marketing | ||||||||
| Professional fees | ||||||||
| Salaries and compensation | ||||||||
| Total operating expenses | ||||||||
| Loss from operations | ( | ) | ( | ) | ||||
| Other income (expense) | ||||||||
| Interest expense | ( | ) | ( | ) | ||||
| Other income | ||||||||
| Gain (Loss) on debt settlement | ( | ) | ||||||
| Other expense | ( | ) | ||||||
| Total other income (expense), net | ( | ) | ( | ) | ||||
| Loss before income tax provision | ( | ) | ( | ) | ||||
| Income tax provision | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Earnings (Loss) Per Share: | ||||||||
| Net loss per common share - basic and diluted | $ | ) | $ | ) | ||||
| Weighted average number of common shares | ||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 2 |
LIMITLESS X HOLDINGS INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
| Preferred Stock B | Preferred Stock C | Preferred Stock A | Preferred Stock D | Common Stock | Common Stock Issuable | Additional Paid-In | Accumulated | Total Stockholder’s | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Capital | deficit | Equity | ||||||||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2023 | $ | $ | $ | | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2024 | $ | $ | $ | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | |||||||||||||||||||||||||||||||||||||||||||||||
| Preferred Stock B | Preferred Stock C | Preferred Stock A | Preferred Stock D | Common Stock | Common Stock Issuable | Additional Paid-In | Accumulated | Total Stockholder’s | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Shares | Amount | Capital | deficit | Equity | ||||||||||||||||||||||||||||||||||||||||||||||
| Balance at December 31, 2024 | | $ | | $ | $ | | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||
| Salaries conversion to common stock | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Issuances of common stock to board of directors for services - conversion from accrued compensation | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Issuances of common stock to board of directors for services | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Consulting services - issuance of common stock | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Restricted stock grants | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Issuances of stock options | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of notes payable to shareholder to preferred stock C | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of notes payable to shareholder to preferred stock C | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of notes payable to related parties to preferred stock C | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Issuance of preferred stock C for services | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of vendor accounts payable to preferred stock C | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Issuances of preferred stock C for compensation | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of notes payable to shareholder to preferred stock D | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Conversion of notes payable to shareholder to preferred stock D | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common stock issuable for borrowings from shareholder | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | ( | ) | ( | ) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2025 | $ | $ | $ | $ | $ | $ | $ | $ | ( | ) | $ | ( | ) | |||||||||||||||||||||||||||||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 3 |
LIMITLESS X HOLDINGS INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| (Unaudited) | ||||||||
| Three Months Ended March 31, | ||||||||
| 2025 | 2024 | |||||||
| Cash flows from operating activities: | ||||||||
| Net loss | $ | ( | ) | $ | ( | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation | ||||||||
| Salaries conversion to common stock | ||||||||
| Gain (Loss) on debt settlement | ||||||||
| Stock compensation expense by issuance of Preferred C | ||||||||
| Issuances of common stock to board of directors for services - conversion from accrued compensation | ||||||||
| Issuances of common stock to board of directors for services | ||||||||
| Consulting services - issuance of common stock | ||||||||
| Restricted stock grants | ||||||||
| Stock option expense | ||||||||
| Stock issued for borrowings | ||||||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivables, net | ( | ) | ||||||
| Inventories | ( | ) | ( | ) | ||||
| Prepaid expenses | ( | ) | ||||||
| Other assets | ||||||||
| Accounts payable and accrued expenses | ( | ) | ||||||
| Royalty payable | ( | ) | ||||||
| Refunds and chargeback payable | ( | ) | ||||||
| Net cash used in operating activities | ( | ) | ( | ) | ||||
| Cash flows from financing activities: | ||||||||
| Repayments on loan payable | ( | ) | ||||||
| Proceeds from borrowings from stockholder | ||||||||
| Proceeds from borrowings from related parties | ||||||||
| Net cash provided by financing activities | ||||||||
| Net increase(decrease) in cash | ( | ) | ( | ) | ||||
| Cash – beginning of period | ||||||||
| Cash – end of period | $ | $ | ||||||
| Supplemental disclosures of cash flow information | ||||||||
| Cash paid during the periods for: | ||||||||
| Interest | $ | $ | ||||||
| Income taxes | $ | $ | ||||||
| Non-cash investing and financing activities: | ||||||||
| Conversion of accrued salaries to common stock | $ | $ | ||||||
| Conversion of loans payable and accrued interest to stockholder to Preferred C Shares | $ | $ | ||||||
| Conversion of loans payable and accrued interest to related parties to Preferred C Shares | $ | $ | ||||||
| Conversion of loans payable and accrued interest to stockholder to Preferred D Shares | $ | $ | ||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
| 4 |
LIMITLESS X HOLDINGS INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – ORGANIZATION AND HISTORY
On May 11, 2022, Bio Lab Naturals, Inc., a Delaware corporation (“Bio Lab”), entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Limitless X, Inc., a Nevada corporation (“LimitlessX”), and its 11 shareholders (the “LimitlessX Acquisition”). The parties completed and closed the LimitlessX Acquisition on May 20, 2022 by issuing an aggregate of shares of common stock of Bio Lab to the LimitlessX shareholders (the “Acquisition Closing”). According to the terms of the Share Exchange Agreement, Bio Lab then issued an additional shares of common stock to the LimitlessX shareholders pro rata to their interests approximately nine months from the Acquisition Closing as part of the LimitlessX Acquisition. Concurrently with the LimitlessX Acquisition, Jaspreet Mathur, the founder and principal shareholder of LimitlessX, also purchased from Helion Holdings LLC, shares of Bio Lab’s Class A Preferred Convertible Stock, which at all times have a number of votes equal to % of all of the issued and outstanding shares of common stock of Bio Lab.
On June 10, 2022, Bio Lab changed its name to Limitless X Holdings Inc. (“Limitless”).
The LimitlessX Acquisition was accounted for as a “reverse merger” following the completion of the transaction. For accounting purposes, LimitlessX was deemed to be the accounting acquirer in the transaction and, consequently, the transaction was treated as a recapitalization of Bio Lab. Accordingly, LimitlessX’s assets, liabilities, and results of operations became the historical financial statements of the registrant. No step-up in basis or intangible assets or goodwill was recorded in this transaction.
The Company (as defined below) is a lifestyle brand, focused in the health and wellness industry. Initially, the Company focused on nutritional supplements, wellness studies, and interactive training videos and has since focused its business on performance marketing, sales of digital services, and sales of products. The Company’s mission is to provide businesses a turnkey solution to sell their products. Company teams include sales, marketing, user interface design (UI), user experience design (UX), fulfillment, customer support, labeling, product manufacturing, consulting, retailing, and payment processing, among others.
The Company currently offers products online only. The Company has manufacturing and distribution licensing agreements to market, manufacture, sell, and distribute branded products on behalf of its clients. The Company orders products from third party partner manufacturers that make the products according to the Company’s custom formulations, and brands them using the Company’s licensed trademarks. Products are then marketed and sold direct to consumers online. Orders are fulfilled and shipped directly from the Company’s licensors. The Company plans to offer global marketing services across all areas of the sales process, including market research, brand and product development, and digital advertising operating as an integrated marketing agency.
The Company operates in the following product and service sectors: (i) health products and (ii) digital marketing services. The health products sector included the sales of health products in two primary vertical markets: (1) health & wellness; and (2) beauty & skincare. The digital marketing service sector includes digital marketing; digital and print design; social media marketing; and direct-to-consumer marketing.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The accompanying unaudited interim consolidated financial statements as of and for the three months ended March 31, 2025 and 2024 have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q. Accordingly, they do not include all of the information and notes required by US GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) considered necessary for a fair presentation have been included. All intercompany balances and transactions have been eliminated in consolidation. Operating results for the three months ended March 31, 2025 are not necessarily indicative of the results that may be expected for any future periods or the year ending December 31, 2025. The accompanying unaudited consolidated financial statements should be read in conjunction with the Company’s 2024 Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on May 9, 2025.
| 5 |
Going Concern
The
accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates,
among other things, the realization of assets and satisfaction of liabilities in the normal course of business. The Company had an accumulated
deficit of approximately $
To support our existing and planned business model, the Company needs to raise additional capital to fund our future operations. The Company has not experienced any difficulty in raising funds through loans and has not experienced any liquidity problems in settling payables in the normal course of business and repaying loans when they fall due. Successful renewal of our loans, however, is subject to numerous risks and uncertainties. In addition, the increasingly competitive industry conditions under which we operate may negatively impacted our results of operations and cash flows. Additional debt financing is anticipated to fund the Company’s operations in near future. However, there are no current agreements or understandings with regard to the form, time or amount of such financing and there is no assurance that any of this financing can be obtained or that the Company can continue as a going concern.
Principles of Consolidation and Reporting
The accompanying consolidated financial statements include the accounts of Limitless X Holdings Inc. (a holding company) and its wholly owned operating subsidiaries: Limitless X, Inc. and Prime Time Live, Inc. (collectively, the “Company”). All intercompany balances have been eliminated during consolidation.
Use of Estimates in the Preparation of Consolidated Financial Statements
The preparation of consolidated financial statements in conformity with generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Estimates also affect the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Segment Reporting
Operating segments comprised of the components of an entity in which separate information is available for evaluation by the Company’s chief operating decision maker, or group of decision makers, in determining how to allocate resources in evaluating performance. The Company consists of a single reporting segment providing direct to consumer e-commerce services for the Company’s health and wellness products, with a primary emphasis on dietary supplements. The Company’s current lead products are NZT-48, NZT-48 Lions mane, NZT-48 For Her and Oneshot Nootropic Pre-Workout.
The Company’s other businesses Limitless Films, Inc. (formed December 2024), XocelForte Therapeutics Inc. (formed in Augusts 2024), Limitless Entertainment, Inc. (December 2024), Limitless Digital Assets, Inc. (formed in December 2024) and Limitless Living Inc. (formed in December 2024) did not have any transactions during 2024 and three months ended March 31, 2025.
The Company’s chief operating decision maker (“CODM”) is its Chief Executive Officer. The accounting policies of the direct-to-consumer ecommerce services segment are as described in the summary of significant accounting policies. The CODM evaluates the performance of the direct-to-consumer ecommerce services segment based on the Company’s net income (loss) as reported in the Statements of Operations. The Company’s segment assets are reported on the Balance Sheets.
| 6 |
The CODM reviews performance based on gross profit, operating profit, net earnings and net earnings. Operating profit is reviewed to monitor the operating and administrative expenses of the Company. Profitability is important to the Company’s ability to grow and expand operations and strategic initiatives. The Company does not have any operations or sources of revenue outside of the United States. The Company does not have any customer representing more than 10% of total revenues for any period presented. Accordingly, the CODM considers the revenue, operating expenses, and other income (expenses) of our single operating segment as reported on the statement of operations and considers our current and total assets as recorded on the balance sheet. There are no additional expense or asset information that are supplemental to those disclosed in these consolidated financial statements that are regularly provided to the CODM.
Cash and Cash Equivalents
The Company considers all liquid investments purchased with an initial maturity of three months or less to be cash equivalents. Cash and cash equivalents include demand deposits carried at cost which approximates fair value. The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”).
Concentration of Credit Risk
The Company offers its products and services to a large number of customers. The risk of non-payment by these customers is considered minimal and the Company does not generally obtain collateral for sales. The Company continually monitors the credit standing of its customers.
Accounts Receivable, net
Accounts receivable, net consists primarily of trade receivables, net of allowances for doubtful accounts. The Company sells its products for cash or on credit terms, which are established in accordance with local and industry practices and typically require payment within 30 days of delivery. The Company estimates its allowance for doubtful accounts and the related expected credit loss based upon the Company’s historical credit loss experience, adjusted for asset-specific risk characteristics, current economic conditions, and reasonable forecasts. Accounts receivables are written off when determined to be uncollectible.
Holdback Receivables
The Company primarily sells its products online using various third-party sales affiliates. These affiliates (online marketing campaign companies) are paid certain commission based on their ability to provide the Company’s products through online sales. All payments are processed through various gateways and are settled through the Company’s payment gateway settler. The Company payment gateway settler is not responsible for settlements that are not paid due to processing bank failure. The Company holds responsibility for all the risk in all transactions and processing systems. The payment gateway settler charges a reserve fee to mitigate the risk on their end for any loss of funds or damages.
Distributions of the holdback receivables from the third-party payment gateway settler are based on several criteria, such as return and chargeback history, associated risk for the specific business vertical, average transaction amount, and so on. In order to mitigate processing risks, there are policies regarding reserve requirements and payment in arrears in place.
The
total holdback receivables balance reflects the
Inventories
Inventories are valued at the lower-of cost or net realizable value on a first-in, first-out basis, adjusted for the value of inventory that is determined to be excess, obsolete, expired, or unsaleable. Inventories primarily consisted of finished goods.
Advertising and Marketing
Advertising
and marketing costs are charged to expense as incurred. Advertising and marketing costs were approximately $
| 7 |
Revenue Recognition
| ● | Product Sales | |
| The Company recognizes revenue when performance obligations under the terms of a contract with a customer are satisfied. The Company has determined that fulfilling and delivering products is a single performance obligation. Revenue is recognized at the point in time when the Company has satisfied its performance obligation and the customer has obtained control of the products. This generally occurs when the product is delivered to or picked up by the customer based on applicable shipping terms, which is typically within 15 days. Revenue is measured as the amount of consideration expected to be received in exchange for fulfilled product orders. | ||
| Customer remedies for defective or non-conforming products may include a refund or exchange. As a result, the right of return is estimated and recorded as a reduction in revenue at the time of sale, if necessary. | ||
| The Company’s customer contracts identify product quantity, price, and payment terms. Payment terms are granted consistent with industry standards. Although some payment terms may be extended, the majority of the Company’s payment terms are less than 30 days. As a result, revenue is not adjusted for the effects of a significant financing component. Amounts billed and due from customers are classified as Accounts Receivables on the Balance Sheet. | ||
| The Company utilizes third-party contract manufacturers for the manufacture of its products. The Company has evaluated whether it is the principal or agent in these relationships. The Company has determined that it is the principal in all cases as it retains the responsibility for fulfillment and risk of loss, as well as for establishing the price. | ||
| In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, the Company has elected the practical expedient to expense the incremental costs to obtain a contract, because the amortization period would be less than one year, and the practical expedient for shipping and handling costs. Shipping and handling costs incurred to deliver products to customers are accounted for as fulfillment activities, rather than a promised service, and as such are included in Cost of Goods Sold in the Statements of Operations. | ||
| ● | Service Revenue | |
| Service revenue consists of digital marketing revenue. Revenue related to digital marketing is recognized over time as services are provided to the customer. The Company sells digital marketing, digital and print design, social media marketing, and direct-to-consumer marketing and thus uses standalone selling prices as the basis for revenue. Payment for digital marketing services is typically received at the point when control transfers to the customer or in accordance with payment terms customary to the business. There was no deferred revenue related to services revenue as of March 31, 2025 and December 31, 2024. |
Cost of Sales
Cost of sales includes the cost of inventory sold during the period, as well as commission fees, returns, chargebacks, distribution, and shipping and handling costs. The amount shown is net of various rebates from third-party vendors in the form of payments.
Refunds Payable
If
customers are not satisfied for any reason, they may request a full refund, processed to the original form of payment, within 30 days
from the order date. If the order has already been shipped, the Company charges a
| 8 |
Chargebacks Payable
Once customers successfully dispute chargebacks with the payment processor, the Company returns such funds to the payment processor to return to the customer.
Income Taxes
The
accounting standard on accounting for uncertainty in income taxes addresses the determination of whether tax benefits claimed or expected
to be claimed on a tax return should be recorded in the financial statements. Under that guidance, the Company may recognize the tax
benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by
taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such a
position are measured based on the largest benefit that has a
The Company calculates earnings per share in accordance with Financial Accounting Standards Board (“FASB”) ASC 260, Earnings Per Share, which requires a dual presentation of basic and diluted earnings per share. Basic earnings per share (“EPS”) is computed by dividing earnings (losses) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. The Company had a loss for the three months ended March 31, 2025 and 2024.
The Company accounts for equity-based payment accruals under authoritative guidance as set forth in the Topics of the ASC. The guidance requires all equity-based payments to employees and non-employees, including grants of employee and non-employee stock options and warrants, to be recognized in the consolidated financial statements based at their fair values. The Company applies the provisions of ASC 718, “Compensation - Stock Compensation,” using a modified prospective application, and the Black-Scholes model to value stock options. Under this application, the Company records compensation expense for all awards granted. Compensation costs will be recognized over the period that an employee provides service in exchange for the award. During the three months ended March 31, 2025 and 2024, the Company granted no securities under its 2020 Stock Incentive Plan, 2022 Restricted Stock Plan, and 2022 Stock Option Plan.
General Concentrations of Risk
Financial instruments that potentially subject the Company to concentrations of credit risk are accounts receivable and other receivables arising from its normal business activities. The Company has a diversified customer base. The Company controls credit risk related to accounts receivable through credit approvals, credit limits, and monitoring procedures. The Company routinely assesses the financial strength of its customers and, based upon factors surrounding the credit risk, establishes an allowance, if required, for uncollectible accounts and, as a consequence, believes that its accounts receivable related credit risk exposure beyond such allowance is limited.
The
Company purchases inventories from a few suppliers, and the Company’s one largest supplier accounted for
Operating Lease
In accordance with ASC 842, Leases, the Company determines whether an arrangement contains a lease at inception. A lease is a contract that provides the right to control an identified asset for a period of time in exchange for consideration. For identified leases, the Company determines whether it should be classified as an operating or finance lease. Operating leases are recorded in the balance sheet as: right-of-use asset (“ROU asset”) and operating lease liability. ROU asset represents the Company’s right to use an underlying asset for the lease term and lease liability represents the Company’s obligation to make lease payments arising from the lease. ROU assets and operating lease liabilities are recognized at the commencement date of the lease and measured based on the present value of lease payments over the lease term. The ROU asset also includes deferred rent liabilities. The Company’s lease arrangements generally do not provide an implicit interest rate. As a result, in such situations the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The Company includes options to extend or terminate the lease when it is reasonably certain that it will exercise that option in the measurement of its ROU asset and liability. Lease expense for the operating lease is recognized on a straight-line basis over the lease term. The Company has month-to-month lease as of March 31, 2025.
| 9 |
Fair Value Measurements
The Company utilizes ASC 820-10, Fair Value Measurement and Disclosure, for valuing financial assets and liabilities measured on a recurring basis. Fair value is defined as the exit price, or the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. The guidance also establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs market participants would use in valuing the asset or liability and are developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the factors market participants would use in valuing the asset or liability. The guidance establishes three levels of inputs that may be used to measure fair value:
| Level 1. | Observable inputs such as quoted prices in active markets; | |
| Level 2. | Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and | |
| Level 3. | Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. |
The carrying value of financial assets and liabilities recorded at fair value is measured on a recurring or nonrecurring basis. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. There were no financial assets or liabilities carried and measured on a nonrecurring basis during the reporting periods. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. There have been no transfers between levels.
Recent Accounting Pronouncements
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures-In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires a public entity to disclose significant segment expenses and other segment items on an annual and interim basis and provide in interim periods all disclosures about a reportable segment’s profit or loss and assets that are currently required annually. Additionally, it requires a public entity to disclose the title and position of the Chief Operating Decision Maker (“CODM”). The ASU does not change how a public entity identifies its operating segments, aggregates them, or applies the quantitative thresholds to determine its reportable segments. The new standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. A public entity should apply the amendments in this ASU retrospectively to all prior periods presented in the financial statements. The Company adopted the ASU beginning with its Form 10-K for the year ended December 31, 2024. However, the adoption of the new standard did not have a material impact on the requisite disclosure in its financial statements.
In November 2024, the FASB issued ASU 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” which is intended to improve disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses in commonly presented expense captions. Such information should allow investors to better understand an entity’s performance, assess future cash flows, and compare performance over time and with other entities. The amendments will require public business entities to disclose in the notes to the financial statements, at each interim and annual reporting period, specific information about certain costs and expenses, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each expense caption presented on the face of the income statement, and the total amount of an entity’s selling expenses. The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, and may be applied either prospectively or retrospectively. Early adoption is permitted. The Company is currently evaluating the impact of adopting this guidance on the consolidated financial statements.
Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force) and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.
| 10 |
NOTE 3 – ROYALTY PAYABLES
Limitless
Performance Inc. (“LPI”), SMILZ INC. (“Smiles”), DIVATRIM INC. (“Divatrim”), and AMAROSE INC. (“Amarose,”
and collectively with LPI, Smiles, and Divatrim, the “Licensors”) are all companies at least 50% owned by a shareholder of
the Company. On December 1, 2021, the Company entered into manufacturing and distributorship license agreements (each, a “License
Agreement”) with each of the Licensors to distribute each of the Licensors’ respective products and for payments to such
Licensor for its product designs and distribution rights. Pursuant to the License Agreements, and each of them, the Company agreed to
pay to such Licensors royalty payments equal to
On October 1, 2023, the Company terminated each of the License Agreements; however, the Company maintained its license for NZT-48 with LPI.
The
Company was required to start paying all earned royalties to each of the Licensors beginning on June 15, 2022. As of October 1, 2023,
the royalty payable was $
As
of March 31, 2025 and December 31, 2024, royalty payables were $
NOTE 4 – NOTE PAYABLE
On
March 1, 2021, an individual loaned Prime Time Live, Inc. $
| March 31, | December 31, | |||||||
| 2025 | 2024 | |||||||
| December 6, 2021 ($) | $ | $ | ||||||
| February 11, 2022 ($) | ||||||||
| May 8, 2022 ($) | ||||||||
| May 16, 2022 ($) | ||||||||
| May 18, 2022 ($) | ||||||||
| June 1, 2022 ($) | ||||||||
| June 30, 2022 ($) | ||||||||
| August 25, 2022 ($) | ||||||||
| November 15, 2022 ($) | ||||||||
| May 16, 2023 ($) | ||||||||
| May 18, 2023 ($) | ||||||||
| June 5, 2023 ($) | ||||||||
| June 20, 2023 ($) – Funding Commitment | ||||||||
| July 13, 2023 ($) – Funding Commitment | ||||||||
| August 1, 2023 ($) – Funding Commitment | ||||||||
| August 7, 2023 ($) – Funding Commitment | ||||||||
| March 23, 2025 ($) | ||||||||
| Total notes payable to stockholder (current) | $ | $ | ||||||
December 6, 2021 – $50,000
On December 6, 2021, the Company entered into a Loan Authorization and Agreement for a loan of $ from a shareholder, the proceeds of which were used to be used for working capital purposes. Beginning on June 1, 2022, the loan required a payment of $ per month, which included principal and interest with an interest rate of % per annum. The total balance of principal and interest of $ was converted to preferred C shares during the three months ended March 31, 2025.
| 11 |
February 11, 2022 – $150,000
On February 11, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $ from a shareholder, the proceeds of which were to be used for working capital purposes. Beginning on June 1, 2022, the loan required a payment of $ per month, which included principal and interest with an interest rate of % per annum. The total balance of principal and interest of $ was converted to preferred C shares during the three months ended March 31, 2025.
May 8, 2022 – $550,000
On May 8, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $ from a shareholder, the proceeds of which were to be used for working capital purposes. Beginning on June 1, 2022, the loan required a payment of $ per month, which included principal and interest with an interest rate of % per annum. The total balance of principal and interest of $ was converted to preferred C shares during the three months ended March 31, 2025.
May 16, 2022 – $1,100,000
On May 16, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $ from a shareholder, the proceeds of which were to be used for working capital purposes. Interest began accruing at the rate of % per annum on June 17, 2022 was converted to preferred C shares during the three months ended March 31, 2025.
May 18, 2022 – $450,000
On May 18, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $ from a shareholder, the proceeds of which were to be used for working capital purposes. Interest began accruing at the rate of % per annum on June 19, 2022 and was due on . During the three months ended March 31, 2025, approximately $ of this amount including accrued interest was converted to preferred C shares and $ including accrued interest was converted to preferred D shares.
June 1, 2022 – $500,000
On June 1, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $ from a shareholder, the proceeds of which were to be used for working capital purposes. Beginning on August 1, 2022, the loan required a payment of $ per month, which included principal and interest with an interest rate of % per annum. The total balance of principal and interest of $ was due on July 1, 2023. During the three months ended March 31, 2025, this amount including accrued interest was converted to preferred D shares.
June 30, 2022 – $922,028
On September 30, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $ from a shareholder, the proceeds of which were to be used for working capital purposes. Beginning on August 1, 2022, the loan required a payment of $ per month, which included principal and interest with an interest rate of % per annum. The total balance of principal and interest of $ was due on August 1, 2023. During the three months ended March 31, 2025, this amount including accrued interest was converted to preferred D shares.
August 25, 2022 – $290,000
On August 25, 2022, the Company entered into a Loan Authorization Agreement for a loan of $ from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of % per annum and is due on demand. During the three months ended March 31, 2025, this amount including accrued interest was converted to preferred D shares.
November 15, 2022 – $450,000
On November 15, 2022, the Company entered into a Loan Authorization and Agreement for a loan of $ from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of % per annum and is due on demand. During the three months ended March 31, 2025, this amount including accrued interest was converted to preferred D shares.
| 12 |
May 16, 2023 – $150,000
On May 16, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $ from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of % per annum and is due on demand. During the three months ended March 31, 2025, this amount including accrued interest was converted to preferred D shares.
May 18, 2023 – $50,000
On May 18, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $ from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of % per annum and is due on demand. During the three months ended March 31, 2025, this amount including accrued interest was converted to preferred D shares.
June 5, 2023 – $150,000
On June 5, 2023, the Company entered into a Loan Authorization and Agreement for a loan of $ from a shareholder, the proceeds of which were to be used for working capital purposes. The loan has an interest rate of % per annum and is due on demand. During the three months ended March 31, 2025, this amount including accrued interest was converted to preferred D shares.
Funding Commitment Agreement
On
June 3, 2023, the Company entered into a Funding Commitment Agreement (the “Funding Commitment”) with its Chief Executive
Officer and Chairman of the Board of Directors, Jaspreet Mathur, wherein Mr. Mathur committed to provide up to $
| March 31, | December 31, | |||||||
| 2025 | 2024 | |||||||
| June 20, 2023 ($) | $ | $ | ||||||
| July 13, 2023 ($) | ||||||||
| August 1, 2023 ($) | ||||||||
| August 7, 2023 ($ original) | ||||||||
| Total notes payable to related parties (current) | $ | $ | ||||||
During the three months ended March 31, 2025, this amount including accrued interest was converted to preferred D shares.
March 21, 2025 – $500,000
On
March 21, 2025, the Company entered into a Loan Authorization and Agreement for a loan of $
| 13 |
NOTE 6 – NOTES PAYABLE TO RELATED PARTIES
Notes payable to related parties consisted of the following:
| March 31, | December 31, | |||||||
| 2025 | 2024 | |||||||
| May 10, 2022 ($ | $ | $ | ||||||
| May 10, 2022 ($ | ||||||||
| May 10, 2022 ($ | ||||||||
| May 31, 2022 ($ | ||||||||
| May 31, 2022 ($ | ||||||||
| June 9, 2022 ($ | ||||||||
| March 27, 2024 ($ | ||||||||
| April 22, 2024 ($ | ||||||||
| April 26, 2024 ($ | ||||||||
| June 25, 2024 ($ | ||||||||
| June 28, 2024, 2024 ($ | ||||||||
| March 15, 2024 ($ | ||||||||
| March 24, 2025 ($ | ||||||||
| Total notes payable to related parties (current) | $ | $ | ||||||
| ● | May 10, 2022 - $12,500 |
On
May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $
| ● | May 10, 2022 - $12,500 |
On
May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $
| ● | May 10, 2022 - $20,000 |
On
May 10, 2022, a related party of the Company loaned Prime Time Live, Inc. $
| ● | May 31, 2022 - $5,000 |
On
May 31, 2022, a related party of the Company loaned Prime Time Live, Inc. $
| ● | May 31, 2022 - $15,000 |
On
May 31, 2022, a related party of the Company loaned Prime Time Live, Inc. $
| ● | June 9, 2022 - $15,000 |
On
June 9, 2022, the Company loaned share holder of the company $
| 14 |
| ● | March 15, 2024 - $419,428 |
On
March 12, 2024, Emblaze One, a company owned by the shareholder of the company, a related party, provided $
| ● | March 27, 2024 - $100,000 |
On
March 12, 2024, EM1 Capital, a company owned by the shareholder of the company, a related party, provided $
| ● | April 22, 2024 - $49,139 |
On
April 22, 2024, EM1 Capital, a company owned by the shareholder of the company, a related party, provided $
| ● | April 26, 2024 - $45,000 |
On
April 26, 2024, EM1 Capital, a company owned by the shareholder of the company, a related party, provided $
| ● | June 25, 2024 - $32,000 |
On
June 25, 2024, EM1 Capital, a company owned by the shareholder of the company, a related party, provided $
| ● | June 28, 2024 - $25,000 |
On
June 28, 2024, EM1 Capital, a company owned by the shareholder of the company, a related party, provided $
| ● | March 24, 2025 - $163,515 |
On
March 24, 2025, Emblaze One, a company owned by the shareholder of the company, a related party, provided $
| 15 |
NOTE 7 – LOAN PAYABLE
The
Company entered into a loan payable agreement in July 2024 in the amount of $
NOTE 8 – STOCKHOLDERS’ DEFICIT
Common Stock
As of March 31, 2025 and December 31, 2024, the Company has authorized shares of common stock par value $ per share.
Preferred Stock
As of March 31, 2025 and December 31, 2024, the Company has authorized shares of preferred stock, shares of which were designated as Class A Convertible Preferred Stock (“Class A Preferred Stock”). and shares of which were designated as Class B Convertible Preferred Stock.
Class A Convertible Stock
As
of March 31, 2025 and December 31, 2024, there were a total of shares of Class A Preferred Stock issued and outstanding. The
Class A Preferred Stock, when voting as a single class, has the votes of at least
Class B Convertible Stock
On
October 23, 2023, pursuant to certain Conversion Agreements, the Company issued an aggregate of shares of Class B Preferred
Stock and extinguished $
On
September 9, 2024, pursuant to the conversion agreement, the convertible B shareholders converted shares of Class B Preferred
Stock in exchange for common stock. The conversion amount of Class B Preferred Stock was $
Class C Convertible Stock
Effective as of January 2, 2025, the Company filed a Certification of Designation of Class C Convertible Preferred Stock (the “Certificate”) with the Delaware Secretary of State and in accordance with the Delaware General Corporation Law. The Company currently has shares of preferred stock (“Preferred Stock”) authorized. Of the authorized shares of Preferred Stock, shares are designated as Class A Convertible Preferred Stock (the “Class A Stock”), all of which are issued and outstanding. Additionally, shares of the Preferred Stock are designated as Class B Convertible Preferred Stock (the “Class B Stock”), of which shares are issued and outstanding. The Company has shares of common stock (“Common Stock”) authorized, of which shares are issued and outstanding. The Certificate designates shares of the Company’s Preferred Stock as Class C Convertible Preferred Stock with a par value of $ per share (“Class C Stock”). The Class C Stock ranks (i) junior to the Class A Stock and Class B Stock, (ii) senior to any other class or series of outstanding Preferred Stock or Common Stock, and (iii) prior to any other class or series of capital stock of the Company hereafter created, and in each case as to distributions of assets upon liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary (the “Class C Stock Distribution Ranking”). The Class C Stock is not entitled to dividends except as required by law. The Class C Stock shall have no voting rights other than as set forth in the Certificate or as required by law.
| 16 |
During the three months ended March 31, 2025, the Company issued the following Class C Convertible Stock:
| ● | Pursuant to the conversion agreement, the notes payable to shareholder including accrued interest in the amount of $ was converted to shares of Class C Preferred Stock. The conversion amount of Class C Preferred Stock was $ at the date of conversion. The Company recognized loss from settlement of debt in the amount of $ during the three months ended March 31, 2025. |
| ● | The Company issued shares of Class C Preferred Stock to Limitless Performance, Inc., related to settlement of license related to manufacturing and distributorship. The company recognized stock compensation expense of $ during the three months ended March 31, 2025 which was the fair value based on common stock trading price at the date of conversion. |
| ● | Pursuant
to the conversion agreement, the notes payable to related party including accrued interest
in the amount of $ |
| ● | The Company issued shares of Class C Preferred Stock to consultant for services. The Company recognized stock compensation expense of $ during the three months ended March 31, 2025 which was the fair value based on common stock trading price at the date of conversion. |
| ● | Pursuant
to the conversion agreement, the vendor accounts payable of $ |
As a result of converting various related party notes payable to preferred C shares, the Company recognized total loss from settlement of debt as summarized below:
Three Months Ended March 31, | ||||
| 2025 | ||||
| Conversion
of $ | $ | |||
| Conversion
of $ | ||||
| Total loss from settlement of notes payable to shareholder and related parties | $ | |||
Class D Convertible Stock
Effective
as of January 23, 2025, the Company filed a Certificate of Designation of Series D
During the three months ended March 31, 2025, the Company issued the following Class D Convertible Stock:
| ● | Pursuant to the conversion agreement, the notes payable to shareholder including accrued interest in the amount of $ was converted to shares of Class D Preferred Stock. The conversion amount of Class C Preferred Stock was $ or $ per share at the date of conversion. |
| ● | On
March 21, 2025, the Company entered into a Loan Authorization and Agreement for a loan of $ |
| 17 |
The Company accounts for equity-based payment accruals under authoritative guidance as set forth in the Topics of the ASC. The guidance requires all equity-based payments to employees and non-employees, including grants of employee and non-employee stock options and warrants, to be recognized in the consolidated financial statements based at their fair values.
Stock Incentive Plans
The Company has the following stock incentive plans:
| ● | Stock Option Plan |
Effective January 15, 2020, the Company adopted its 2020 Stock Option and Award Plan (the “2020 Stock Incentive Plan”). A total of shares of the Company’s common stock were reserved for the 2020 Stock Incentive Plan. As of March 31, 2025 and December 31, 2024, there were grants made under the 2020 Stock Incentive Plan. On May 4, 2023, the Company terminated the 2020 Stock Incentive Plan.
Effective August 9, 2022, the Company adopted its 2022 Incentive and Non-statutory Stock Option Plan (the “2022 Stock Option Plan”). Under the 2022 Stock Option Plan, the Board of Directors may grant options to purchase common stock to officers, employees, and other persons who provide services to the Company. A total of shares of the Company’s common stock is reserved for the 2022 Stock Option Plan.
The Company granted and issued the following stock options during the three months ended March 31, 2025:
| ○ | The Company granted and issued shares of common stock under the 2022 Stock Option Plan to its employees during the three months ended March 31, 2025. Under the stock option grant, these shares were fully vested at the time of issuance with no exercise price. The common stock share trading price was $ per share at the time of issuances and the Company recognized $ as stock compensation expense during the three months ended March 31, 2025. |
| ● | Restricted Stock Plan |
Effective August 9, 2022, the Company adopted its 2022 Restricted Stock Plan (the “2022 Restricted Stock Plan”). Under the 2022 Restricted Stock Plan, the Board of Directors may grant restricted stock to officers, directors, and key employees. A total of shares of common stock is reserved for the 2022 Restricted Stock Plan.
The Company granted and issued the following restricted stock during the three months ended March 31, 2025:
| ○ | The Company granted and issued shares of common stock under the 2022 Restricted Stock Plan to its employees during the three months ended March 31, 2025. Under the plan, these shares were fully vested at the time of issuance with no exercise price. The common stock share trading price was $ per share at the time of issuances and the Company recognized $ as stock compensation expense during the three months ended March 31, 2025. |
| 18 |
Stock Compensation - Others
At time to time, the Company issues common stock to its Board of Directors, outside service providers or consultants.
The Company had the following common stock issuances during the three months ended March 31, 2025:
| ● | Issuances
of Shares for Accrued Board of Directors Compensation Settlement – The Company
issued common stock shares to its Board of Directors for prior year services of
which the Company had accrued $ |
| ● | Issuances of Shares for Board of Directors Compensation – The Company issued common stock shares to its Board of Directors for its services. The common stock share trading price was $ per share at the time of issuance and the Company recognized $ as stock compensation expense during the three months ended March 31, 2025. |
| ● | Issuances
of Shares to Consultants for Services – The Company issued common stock
shares to consultants. Some of these consultants require entire year of 2025 services, therefore,
some of stock compensation expense of $ was recorded as prepaid at March 31, 2025.
The prepaid amount was $ |
| ● | Issuances
of Shares for Accrued Salaries Settlement – The Company issued common
stock shares to its employees for prior year accrued wages of $ |
| ● | Common
Stock and Preferred D Shares Issuable from Additional Borrowings from Notes Payable to Shareholder
($500,000) – On March 21, 2025, the Company entered into a Loan Authorization
and Agreement for a loan of $ |
NOTE 10 – RELATED PARTY TRANSACTIONS
The Company had the following related party transactions:
| ● | Royalty
Payables – Limitless Performance Inc. (“LPI”), SMILZ INC. (“Smiles”), DIVATRIM INC. (“Divatrim”),
and AMAROSE INC. (“Amarose,” and collectively with LPI, Smiles, and Divatrim, the “Licensors”) are all companies
at least 50% owned by a shareholder of the Company. On December 1, 2021, the Company entered into manufacturing and distributorship
license agreements (each, a “License Agreement”) with each of the Licensors to distribute each of the Licensors’
respective products and for payments to such Licensor for its product designs and distribution rights. Pursuant to the License Agreements,
and each of them, the Company agreed to pay to such Licensors royalty payments equal to |
| ● | Notes
Payable to Shareholder – The Company had various notes payable with its shareholder who is the Chief Executive Officer of
the Company. As of March 31, 2025 and December 31, 2024, the Company had $ | |
| ● | Notes
Payable to Related Parties – The Company entered into various notes payable with shareholders of the Company. As of March
31, 2025 and December 31, 2024, the Company had $ | |
NOTE 11 – COMMITMENTS AND CONTINGENCIES
Contingencies
From time to time, the Company may be involved in certain legal actions and claims arising in the normal course of business. Management is of the opinion that such matters will be resolved without material effect on the Company’s financial condition or results of operations. The Company did not have any legal actions or claims that have a material effect on the results of operation or financial position of the Company.
NOTE 12 – SUBSEQUENT EVENTS
The Company evaluated all events or transactions that occurred after March 31, 2025. During this period, the Company did not have any material recognizable subsequent events required to be disclosed other than the following:
| ● | Common
Stock and Preferred C Shares Issuances (April 10, 2025) – On March 21, 2025,
the Company entered into a Loan Authorization and Agreement for a loan of $ |
| ● | The Company issued common shares on May 6, 2025 to a consultant for consulting services. |
| 19 |
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Forward-Looking Statements and Associated Risks.
This Quarterly Report on Form 10-Q contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, words such as “may,” “expect,” “believe,” “anticipate,” “estimate,” “continue” or comparable terminology are intended to identify forward-looking statements. These statements by their nature involve substantial risks and uncertainties, and actual results may differ materially depending on a variety of factors, many of which are not within our control. These factors include but are not limited to economic conditions generally and in the industries in which we may participate; competition within our chosen industry, including competition from much larger competitors; and failure to successfully develop business relationships.
INTRODUCTION
On May 11, 2022, Bio Lab Naturals, Inc., a Delaware corporation (“Bio Lab”), entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Limitless X, Inc., a Nevada corporation (“LimitlessX”), and its 11 shareholders (the “LimitlessX Acquisition”). The parties completed and closed the LimitlessX Acquisition on May 20, 2022 by issuing an aggregate of 3,233,334 shares of common stock of Bio Lab to the LimitlessX shareholders (the “Acquisition Closing”). According to the terms of the Share Exchange Agreement, Bio Lab then issued an additional 300,000 shares of common stock to the LimitlessX shareholders pro rata to their interests in approximately nine months from the Acquisition Closing as part of the Limitless Acquisition. Concurrently with the LimitlessX Acquisition, Jaspreet Mathur, the founder and principal shareholder of LimitlessX, also purchased from Helion Holdings LLC, 500,000 shares of Bio Lab’s Class A Preferred Convertible Stock, which at all times have a number of votes equal to 60% of all of the issued and outstanding shares of common stock of Bio Lab.
For accounting purposes, the LimitlessX Acquisition was accounted for as a “reverse merger” with LimitlessX as the accounting acquiror (legal acquiree) and Bio Lab as the accounting acquiree (legal acquiror). And, consequently, the transaction was treated as a recapitalization of Bio Lab. Since LimitlessX was deemed to be the accounting acquiror in the LimitlessX Acquisition, the historical financial information for periods prior to the LimitlessX Acquisition reflect the financial information and activities solely of LimitlessX and not of Bio Lab. No step-up in basis or intangible assets or goodwill was recorded in this transaction.
On June 10, 2022, Bio Lab changed its name to Limitless X Holdings Inc. (“we,” “us,” or “our”).
| 20 |
RESULTS OF OPERATION
For the Three Months Ended March 31, 2025 Compared to the Three Months Ended March 31, 2024:
| Three Months Ended March 31, | ||||||||||||||||||||||||
| (restated) | ||||||||||||||||||||||||
| 2025 | 2024 | Changes | ||||||||||||||||||||||
| % of | % of | |||||||||||||||||||||||
| Amount | Sales | Amount | Sales | Amount | % | |||||||||||||||||||
| Revenue | ||||||||||||||||||||||||
| Product sales | $ | 251,936 | 100.0 | % | $ | 1,022,525 | 100.0 | % | $ | (770,589 | ) | -75.4 | % | |||||||||||
| Total revenue | 251,936 | 100.0 | % | 1,022,525 | 100.0 | % | (770,589 | ) | -75.4 | % | ||||||||||||||
| Cost of sales | ||||||||||||||||||||||||
| Cost of sales | 117,194 | 46.5 | % | 241,602 | 23.6 | % | (124,408 | ) | -51.5 | % | ||||||||||||||
| Total cost of sales | 117,194 | 46.5 | % | 241,602 | 23.6 | % | (124,408 | ) | -51.5 | % | ||||||||||||||
| Gross profit | 134,742 | 53.5 | % | 780,923 | 76.4 | % | (646,181 | ) | -82.7 | % | ||||||||||||||
| Operating expenses: | ||||||||||||||||||||||||
| General and administrative | 170,866 | 67.8 | % | 256,747 | 25.1 | % | (85,881 | ) | -33.4 | % | ||||||||||||||
| Advertising and marketing | 191,134 | 75.9 | % | 721,678 | 70.6 | % | (530,544 | ) | -73.5 | % | ||||||||||||||
| Professional fees | 3,420,935 | 1357.9 | % | 280,066 | 27.4 | % | 3,140,869 | 1121.5 | % | |||||||||||||||
| Salaries and compensation | 583,851 | 231.7 | % | 497,188 | 48.6 | % | 86,663 | 17.4 | % | |||||||||||||||
| Total operating expenses | 4,366,786 | 1733.3 | % | 1,755,679 | 171.7 | % | 2,611,107 | 148.7 | % | |||||||||||||||
| Income (loss) from operations | (4,232,044 | ) | -1679.8 | % | (974,756 | ) | -95.3 | % | (3,257,288 | ) | 334.2 | % | ||||||||||||
| Other income (expense) | ||||||||||||||||||||||||
| Interest expense | (463,397 | ) | -183.9 | % | (100,964 | ) | -9.9 | % | (362,433 | ) | 359.0 | % | ||||||||||||
| Other income | 2,428 | 1.0 | % | 7,902 | 0.8 | % | (5,474 | ) | -69.3 | % | ||||||||||||||
| Other expense | - | 0.0 | % | (10,325 | ) | -4.1 | % | 10,325 | -100.0 | % | ||||||||||||||
| Gain (Loss) on debt settlement | (29,926,400 | ) | -11878.6 | % | - | 0.0 | % | (29,926,400 | ) | n/a | ||||||||||||||
| Gain (loss) on disposal of assets | - | 0.0 | % | - | 0.0 | % | - | n/a | ||||||||||||||||
| Total other income (expense), net | (30,387,369 | ) | -12061.5 | % | (103,387 | ) | -10.1 | % | (30,283,982 | ) | 29291.9 | % | ||||||||||||
| Income (loss) before income tax provision | (34,619,413 | ) | -13741.4 | % | (1,078,143 | ) | -105.4 | % | (33,541,270 | ) | 3111.0 | % | ||||||||||||
| Income tax provision | - | 0.0 | % | - | 0.0 | % | - | n/a | ||||||||||||||||
| Net income (loss) | $ | (34,619,413 | ) | -13741.4 | % | $ | (1,078,143) | -105.4 | % | $ | (33,541,270 | ) | 3111.0 | % | ||||||||||
| 21 |
Product Sales - Our product sales decreased by $0.8 million to $0.3 million for the three months ended March 31, 2025 as compared to $1.0 million for the three months ended March 31, 2024. In 2024, there was a shift in our marketing and selling strategies, including a change in performance marketers and platforms, which resulted in the decrease of product sales.
Cost of Sales - Our cost of sales decreased from $0.2 million, or 23.6% of sales, in the three months ended March 31, 2024 to $0.1 million, or 46.5% of sales, in the three months ended March 31, 2025. As operations decreased during the period, so did our costs for freight, inventory, and other supplies.
Gross Profit - Gross profit for the three months ended March 31, 2025 was $0.1 million compared to $0.8 million for the three months ended March 31, 2024. The decrease in gross profit of $0.7 million was primarily due to a shift in our marketing and selling strategies, including a change in performance marketers and platforms.
Operating Expenses - During the three months ended March 31, 2025, we recognized $4.4 million in operating expenses compared to $1.8 million for the three months ended March 31, 2024. The increase of $2.6 million in operating expenses was primarily due to the increase in stock compensation expenses related to stock options issued, restricted stocks issued, and stocks issued for services.
Other Income or Expense - During the three months ended March 31, 2025, we had loss on settlement of debt due to conversion of loans payable to shareholders in the amount of $30.0 million compared to none in prior year same quarter. The Company also recorded interest expense of $0.5 million during the three months ended March 31, 2025 compared to $0.1 million during the three months ended March 31, 2024.
LIQUIDITY AND CAPITAL RESOURCES
Operating Activities
During the three months ended March 31, 2025, net cash used in operating activities was $0.8 million. The cash used in operating activities was primarily due to net loss of approximately $23.4 million and off-set by loss on settlement of debt of $20.2 million.
Financing Activities
Net cash provided by financing activities for the three months ended March 31, 2025 was $0.8 million. This amount was incurred by increased borrowings from a stockholder.
Off Balance Sheet Arrangements
None.
| 22 |
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) under the Exchange Act. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.
Based on management’s evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as a result of the material weakness described below, as of March 31, 2025, our disclosure controls and procedures were not effective. Our disclosure controls were not designed at a reasonable assurance level and are ineffective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
The material weakness, which relates to internal control over financial reporting, that was identified is:
We did not have sufficient personnel in our accounting and financial reporting functions. As a result, we were not able to achieve adequate segregation of duties and were not able to provide for independent adequate reviewing of the financial statements. This control deficiency, which is pervasive in nature, results in a reasonable possibility that material misstatements of the financial statements will not be prevented or detected on a timely basis.
Management believes that the hiring of additional personnel who have the technical expertise and knowledge with the non-routine or technical issues we have encountered in the past will result in both proper recording of these transactions and a much more knowledgeable finance department as a whole. Due to the fact that our accounting staff consists of a Chief Financial Officer, a bookkeeper, and external accounting consultants, additional personnel will also ensure the proper segregation of duties and provide more checks and balances within the department. Additional personnel will also provide the cross training needed to support us if personnel turnover issues within the department occur. We believe this will eliminate or greatly decrease any control and procedure issues we may encounter in the future.
We will continue to monitor and evaluate the effectiveness of our disclosure controls and procedures and our internal controls over financial reporting on an ongoing basis and are committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.
| 23 |
PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
None.
ITEM 1A. RISK FACTORS
Our Annual Report on Form 10-K, filed with the SEC, on December 31, 2024, describes important risk factors that could cause our business, financial condition, results of operations, and growth prospects to differ materially from those indicated or suggested by forward-looking statements made in this Quarterly Report on Form 10-Q or presented elsewhere by management from time to time. There have been no material changes in the risk factors that appear in our Annual Report on Form 10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect our business.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURE
Not Applicable.
ITEM 5. OTHER INFORMATION
Our
directors and executive officers may from time to time enter into plans or other arrangements for the purchase or sale of our common
stock that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or may represent a non-Rule 10b5-1 trading arrangement
under the Exchange Act. During the quarter ended March 31, 2025, no such plans or other arrangements were
ITEM 6. EXHIBITS
Exhibits. The following is a complete list of exhibits filed as part of this Form 10-Q. Exhibit numbers correspond to the numbers in the Exhibit Table of Item 601 of Regulation S-K.
*Filed herewith
| 24 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| LIMITLESS X HOLDINGS INC. | ||
| (Registrant) | ||
| Dated: May 21, 2025 | By: | /s/ Jaspreet Mathur |
| Jaspreet Mathur | ||
| (Chief Executive Officer, | ||
| Principal Executive Officer) | ||
| Dated: May 21, 2025 | By: | /s/ Benjamin Chung |
| Benjamin Chung | ||
(Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer) | ||
| 25 |